
Profitability, historical returns, and peer comparisons.
According to Orion Oyj’s latest financial reports and current stock price. The company's current ROE is 51.93%. This represents a change of 304.34% compared to the average of 12.84% of the last 4 quarters.
The mean historical ROE of Orion Oyj over the last ten years is 33.11%. The current 51.93% ROE has changed 56.81% with respect to the historical average. Over the past ten years (40 quarters), ORINY's ROE was at its highest in in the June 2018 quarter at 26.44%. The ROE was at its lowest in in the December 2022 quarter at 3.48%.
Average
33.11%
Median
33.04%
Minimum
24.36%
Maximum
42.72%
Discovering the peaks and valleys of Orion Oyj ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 48.53%
Maximum Annual ROE = 42.72%
Minimum Annual Increase = -39.82%
Minimum Annual ROE = 24.36%
| Year | ROE | Change |
|---|---|---|
| 2025 | 38.95% | 18.65% |
| 2024 | 32.83% | 34.77% |
| 2023 | 24.36% | -36.71% |
| 2022 | 38.49% | 48.53% |
| 2021 | 25.91% | -13.83% |
| 2020 | 30.07% | 16.95% |
| 2019 | 25.71% | -39.82% |
| 2018 | 42.72% | 28.49% |
| 2017 | 33.25% | -14.39% |
| 2016 | 38.84% | 10.98% |
The current ROE of Orion Oyj (ORINY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
32.04%
5-year avg
32.11%
10-year avg
33.11%
Orion Oyj’s ROE is less than Ono Pharmaceutical Co., Ltd. (8.69%), greater than Gilead Sciences, Inc. (-21.74%), less than Pfizer Inc. (4.60%), less than Astellas Pharma Inc. (20.41%), less than Daiichi Sankyo Company, Limited (16.51%), less than GSK plc (24.64%), less than Merck & Co., Inc. (5.29%), less than Biogen Inc. (1.86%), less than Sanofi (5.52%), less than AstraZeneca PLC (22.31%),
| Company | ROE | Market cap |
|---|---|---|
| 8.69% | $7.07B | |
| -21.74% | $216.35B | |
| 4.60% | $175.49B | |
| 20.41% | $28.69B | |
| 16.51% | $34.29B | |
| 24.64% | $102.99B | |
| 5.29% | $370.91B | |
| 1.86% | $37.61B | |
| 5.52% | $113.74B | |
| 22.31% | $293.13B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orion Oyj using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Orion Oyj or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Orion Oyj's ROE?
How is the ROE calculated for Orion Oyj (ORINY)?
What is the highest ROE for Orion Oyj (ORINY)?
What is the 3-year average ROE for Orion Oyj (ORINY)?
What is the 5-year average ROE for Orion Oyj (ORINY)?
How does the current ROE for Orion Oyj (ORINY) compare to its historical average?